Literature DB >> 23223931

Adipose tissue biology and cardiomyopathy: translational implications.

Aslan T Turer1, Joseph A Hill, Joel K Elmquist, Philipp E Scherer.   

Abstract

It is epidemiologically established that obesity is frequently associated with the metabolic syndrome and poses an increased risk for the development of type 2 diabetes mellitus and cardiovascular disease. The molecular links that connect the phenomenon of obesity, per se, with insulin resistance and cardiovascular disease are still not fully elucidated. It is increasingly apparent that fully functional adipose tissue can be cardioprotective by reducing lipotoxic effects in other peripheral tissues and by maintaining a healthy balance of critical adipokines, thereby allowing the heart to maintain its full metabolic flexibility. The present review highlights both basic and clinical findings that emphasize the complex interplay of adipose tissue physiology and adipokine-mediated effects on the heart exerted by either direct effects on cardiac myocytes or indirect actions via central mechanisms through sympathetic outflow to the heart.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23223931      PMCID: PMC3532954          DOI: 10.1161/CIRCRESAHA.111.262493

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  183 in total

1.  Role of mTOR in the degradation of IRS-1: regulation of PP2A activity.

Authors:  David Hartley; Geoffrey M Cooper
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

2.  Pericardial adipose tissue, atherosclerosis, and cardiovascular disease risk factors: the Jackson Heart Study: comment on Liu et Al.

Authors:  Gianluca Iacobellis; Alexis Elias Malavazos
Journal:  Diabetes Care       Date:  2010-09       Impact factor: 19.112

3.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.

Authors:  Saverio Cinti; Grant Mitchell; Giorgio Barbatelli; Incoronata Murano; Enzo Ceresi; Emanuela Faloia; Shupei Wang; Melanie Fortier; Andrew S Greenberg; Martin S Obin
Journal:  J Lipid Res       Date:  2005-09-08       Impact factor: 5.922

4.  Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety).

Authors:  A Garg
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

5.  High leptin and resistin expression in chronic heart failure: adverse outcome in patients with dilated and inflammatory cardiomyopathy.

Authors:  Peter Bobbert; Alexander Jenke; Thomas Bobbert; Uwe Kühl; Ursula Rauch; Dirk Lassner; Carmen Scheibenbogen; Wolfgang Poller; Heinz-Peter Schultheiss; Carsten Skurk
Journal:  Eur J Heart Fail       Date:  2012-07-04       Impact factor: 15.534

6.  Adipose tissue mass and location affect circulating adiponectin levels.

Authors:  A T Turer; A Khera; C R Ayers; C B Turer; S M Grundy; G L Vega; P E Scherer
Journal:  Diabetologia       Date:  2011-07-22       Impact factor: 10.122

7.  Adiponectin acts in the brain to decrease body weight.

Authors:  Yong Qi; Nobuhiko Takahashi; Stanley M Hileman; Hiralben R Patel; Anders H Berg; Utpal B Pajvani; Philipp E Scherer; Rexford S Ahima
Journal:  Nat Med       Date:  2004-04-11       Impact factor: 53.440

8.  Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality.

Authors:  Abel Romero-Corral; Virend K Somers; Justo Sierra-Johnson; Yoel Korenfeld; Simona Boarin; Josef Korinek; Michael D Jensen; Gianfranco Parati; Francisco Lopez-Jimenez
Journal:  Eur Heart J       Date:  2009-11-20       Impact factor: 29.983

9.  The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study.

Authors:  M S Lauer; K M Anderson; W B Kannel; D Levy
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  32 in total

Review 1.  Heart failure and loss of metabolic control.

Authors:  Zhao V Wang; Dan L Li; Joseph A Hill
Journal:  J Cardiovasc Pharmacol       Date:  2014-04       Impact factor: 3.105

2.  Arsenic-stimulated lipolysis and adipose remodeling is mediated by G-protein-coupled receptors.

Authors:  D Yesica Garciafigueroa; Linda R Klei; Fabrisia Ambrosio; Aaron Barchowsky
Journal:  Toxicol Sci       Date:  2013-05-06       Impact factor: 4.849

3.  Adipocyte-specific loss of PPARγ attenuates cardiac hypertrophy.

Authors:  Xi Fang; Matthew J Stroud; Kunfu Ouyang; Li Fang; Jianlin Zhang; Nancy D Dalton; Yusu Gu; Tongbin Wu; Kirk L Peterson; Hsien-Da Huang; Ju Chen; Nanping Wang
Journal:  JCI Insight       Date:  2016-10-06

Review 4.  Nutrient sensing and utilization: Getting to the heart of metabolic flexibility.

Authors:  Timothy M Griffin; Kenneth M Humphries; Michael Kinter; Hui-Ying Lim; Luke I Szweda
Journal:  Biochimie       Date:  2015-10-22       Impact factor: 4.079

5.  Early ventricular remodeling and dysfunction in obese children and adolescents.

Authors:  Aura A Sanchez; Gautam K Singh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-10

6.  Obesity-related cardiomyopathy is an adipocyte-mediated paracrine disease.

Authors:  Jane A Leopold
Journal:  Trends Cardiovasc Med       Date:  2014-10-02       Impact factor: 6.677

Review 7.  Mechanisms of heart failure in obesity.

Authors:  Imo A Ebong; David C Goff; Carlos J Rodriguez; Haiying Chen; Alain G Bertoni
Journal:  Obes Res Clin Pract       Date:  2014-01-06       Impact factor: 2.288

8.  The Gift of Light: Using Multiplexed Optical Imaging to Probe Cardiac Metabolism in Health and Disease.

Authors:  Mirwais Wardak; Patricia K Nguyen
Journal:  Circ Cardiovasc Imaging       Date:  2018-03       Impact factor: 7.792

9.  Adiponectin: Just Along for the Ride?

Authors:  Aslan T Turer; Philipp E Scherer
Journal:  Circ Res       Date:  2016-07-22       Impact factor: 17.367

Review 10.  Pathological ventricular remodeling: mechanisms: part 1 of 2.

Authors:  Jana S Burchfield; Min Xie; Joseph A Hill
Journal:  Circulation       Date:  2013-07-23       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.